One in 37 type 2 diabetics taking a commonly prescribed drug will have a heart attack
A study by Northwestern University found that sulfonylureas and basal insulin - which are given to patients if metformin fails - make them more at risk than the newer drug class DPP-4 inhibitors.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Health | Heart | Heart Attack | Insulin | Metformin | Study